1.scRNA-seq reveals that origin recognition complex subunit 6 regulates mouse spermatogonial cell proliferation and apoptosis via activation of Wnt/β-catenin signaling.
Shi-Wei LIU ; Jia-Qiang LUO ; Liang-Yu ZHAO ; Ning-Jing OU ; CHAO-YANG ; Yu-Xiang ZHANG ; Hao-Wei BAI ; Hong-Fang SUN ; Jian-Xiong ZHANG ; Chen-Cheng YAO ; Peng LI ; Ru-Hui TIAN ; Zheng LI ; Zi-Jue ZHU
Asian Journal of Andrology 2023;26(1):46-56
The regulation of spermatogonial proliferation and apoptosis is of great significance for maintaining spermatogenesis. The single-cell RNA sequencing (scRNA-seq) analysis of the testis was performed to identify genes upregulated in spermatogonia. Using scRNA-seq analysis, we identified the spermatogonia upregulated gene origin recognition complex subunit 6 (Orc6), which is involved in DNA replication and cell cycle regulation; its protein expression in the human and mouse testis was detected by western blot and immunofluorescence. To explore the potential function of Orc6 in spermatogonia, the C18-4 cell line was transfected with control or Orc6 siRNA. Subsequently, 5-ethynyl-2-deoxyuridine (EdU) and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assays, flow cytometry, and western blot were used to evaluate its effects on proliferation and apoptosis. It was revealed that ORC6 could promote proliferation and inhibit apoptosis of C18-4 cells. Bulk RNA sequencing and bioinformatics analysis indicated that Orc6 was involved in the activation of wingless/integrated (Wnt)/ β-catenin signaling. Western blot revealed that the expression of β-catenin protein and its phosphorylation (Ser675) were significantly decreased when silencing the expression of ORC6. Our findings indicated that Orc6 was upregulated in spermatogonia, whereby it regulated proliferation and apoptosis by activating Wnt/β-catenin signaling.
2.Mental Health Status and Influencing Factors of Pediatricians in Guangzhou
Yan-ling LAN ; Ru-hao XIANG ; Zong-xuan FENG ; Xin-yi ZHANG ; Yi-hui WANG ; Ou-dong XIA
Journal of Sun Yat-sen University(Medical Sciences) 2023;44(1):138-144
ObjectiveTo investigate the mental health of pediatricians in Guangzhou and its influencing factors, and to provide countermeasures for improving the mental health of pediatricians. MethodsA stratified random sampling method was used to randomly select 400 pediatricians in 11 districts of Guangzhou, and they were surveyed using the Symptom Check List(SCL-90) and the Job Stressor Scale. ResultsThe top three job stressors scored by pediatricians in Guangzhou were external environment (3.23±0.59), workload (3.19±0.56), and organizational management (2.74±0.55). All factor scores were higher than those of the clinician group except for career interest, and the difference was statistically significant (P<0.01). The number of pediatricians with mental health problems was 109, accounting for 27.25%. All factor scores were higher than the physician norm except for anxiety and paranoia. The correlations between each factor of work stressors and each factor of SCL-90 were positive and statistically significant (P<0.05), except for two pairs of factors, workload and terror as well as external environment and terror. The results of univariate analysis showed statistically significant differences in the mental health scores of pediatricians with different health status, years of work experience, job satisfaction, job stress, and career prospects (P<0.05). The results of multiple linear regression showed that health status, years of work experience, professional interest, interpersonal relationship, and doctor-patient relationship were influential factors in the mental health of pediatricians (P<0.05). ConclusionThe mental health of pediatricians in Guangzhou is unsatisfactory, and the factors affecting them are mainly external objective factors such as workload and organizational management.
3. Effects of combined administration of loganin and berberine on bone metabolism in diabetic mice
Xuan DAI ; Zi-Meng-Wei YE ; Ya-Ge LIU ; Bei-Bei CHEN ; Ru-Yuan ZHU ; Bing-Ke XIA ; Hao ZHANG ; Dong-Wei ZHANG ; Xin-Xiang WANG ; Li-Li WANG
Chinese Pharmacological Bulletin 2022;38(2):239-247
Aim To investigate the effects of combined administration of loganin and berberine on bone structure and metabolism in diabetic mice and its potential mechanism.Methods The diabetic ICR mouse model was induced by high fat diet(HFD).After 10 weeks of combined intervention, the effects of loganin and berberine on body weight, body fat rate, blood glucose, blood lipid and serum oxidative stress levels were observed.Bone microstructure was scanned by micro-CT.Biomechanical characteristics of bone were measured by three-point bending test, and material properties were detected by fourier transform infrared(FTIR).The pathological changes were observed by HE and TRAP staining.Protein expressions involved in advanced glycation end products(AGEs)and their receptors(RAGE)/nuclear factor-κB(NF-κB)signaling pathway were detected by immunohistochemistry.Results The combined administration of loganin and berberine could significantly inhibit the weight gain, reduce the levels of blood glucose, blood lipid and oxidative stress, as well as improve glucose tolerance.In addition, combined intervention also decreased the expression levels of the proteins involved in AGEs/RAGE/NF-κB signaling pathway, and improved bone microstructure, finally contributing to increasing bone quality in diabetic mice.Conclusions The combination of loganin and berberine could improve bone metabolism in diabetic mice, which may be related to AGEs/RAGE/NF-κB signaling pathway.
4.Dysbiosis of lung commensal bacteria in the process of lung epithelial-mesenchymal transition in mice with silicosis
China Occupational Medicine 2022;49(05):514-
Objective -
To investigate the effect of lung flora dysbiosis on the process of pulmonary fibrosis and lung epithelial
( ) Methods -
mesenchymal transition EMT in mice with silicosis. Male C57BL/6 mice of specific pathogen free grade were
, , , ( )
randomly divided into the blank control group silicosis model group solvent control group vancomycin VM + ampicillin
( ) , ( ) ( ) ,
AMP group metronidazole MNZ + neomycin NEO group and mixed treatment group 12 mice in each group. Except for
, ,
the blank control group which was given 20.0 µL of 0.9% NaCl solution the other five groups of mice were dosed with 20.0 µL
of silica dust suspension at a mass concentration of 250.0 g/L using a single tracheal drip to establish the silicosis mouse model.
:
The intranasal drip method was used to treat silicosis mice in each group as following mice in the solvent control group were
- ; ;
given double distilled water mice in the VM+AMP group were given VM at a mass concentration of 0.5 g/L and AMP at 1.0 g/L
;
mice in the MNZ+NEO group were given MNZ at a mass concentration of 1.0 g/L and NEO at 1.0 g/L mice in the mixed
,
treatment group were given the same doses of the four antibiotics mentioned above all in a drip volume of 50.0 µL. Silicosis
, ,
mice were treated seven days and half an hour before silica dusting and 7 14 and 21 days after silica dusting. Mouse lungtissue was collected aseptically 28 days after silica dusting. Hematoxylin eosin and Masson trichrome staining methods were
-
used to observe the pathological changes. Western blotting was used to detect the relative protein expression of α smooth muscle
( - ), - ( - ) ( )
actin α SMA E cadherin E CAD and vimentin VIM . Immunohistochemistry was used to detect the relative expression of
- -
E CAD and VIM. Real time fluorescence quantitative polymerase chain reaction was used to detect the expression levels of
(Col1a2) Results
collagen type Ⅰ alpha 2 mRNA in lung tissues. The histopathological results showed that the alveoli of the
,
blank control group were thin and structurally intact with few surrounding infiltrating inflammatory cells and no abnormal
,
distribution of collagen fibers. The alveoli of the silicosis model group were structurally disorganized with a large number of
, ,
infiltrating inflammatory cells thickened alveolar walls and cellular fibrous nodules with abundant blue collagen deposit. In the
, ,
VM+AMP group MNZ+NEO group and the mixed treatment group the inflammation and fibrosis were reduced with diferent
degrees in the lung tissues compared to the silicosis model group and the solvent control group. The relative expression levels of
- , Col1a2
α SMA VIM protein and mRNA in lung tissues of mice in the silicosis model group were higher than those in the blank
( P ), -CAD
control group all <0.05 and the relative expression levels of E protein were lower than those in the blank control
(P ) - , Col1a2
group <0.05 . The relative expression levels of α SMA VIM protein and mRNA in lung tissues of mice in the MNZ+
( P ), -CAD
NEO group and the mixed treatment group were lower all <0.05 and the relative expression levels of E protein were
(P ), Conclusion
higher <0.05 when compared with the silicosis model group and the solvent control group. Pulmonary fibrosis
, -
was reduced in silicosis mice with interventions in lung flora where anaerobic and gram negative bacteria affected pulmonary
fibrosis and dysbiosis of the lung flora affected pulmonary EMT.
5.Effect of Auricular Acupoint Bloodletting plus Auricular Acupressure on Sleep Quality and Neuroendocrine Level in College Students with Primary Insomnia: A Randomized Controlled Trial.
Hao CHEN ; Ming-Jian ZHANG ; Jia-Ai WU ; Yan-Fen SHE ; Xin-Ru YUAN ; Yun-Xiang HUO ; Huan SUN ; Dao-Nan LIU ; Xu-Liang SHI
Chinese journal of integrative medicine 2022;28(12):1096-1104
OBJECTIVE:
To evaluate the effects of auricular acupoint bloodletting (AB) and auricular acupressure (AA) on sleep quality and the levels of melatonin (MT), glutamic acid (Glu), and γ -aminobutyric acid (GABA) in college students with primary insomnia, and to explore the possible mechanism.
METHODS:
Totally 74 college students at Hebei University of Chinese Medicine with primary insomnia were selected from October 2019 to October 2020. All patients were assigned to AB+AA group (37 cases, received combination of AB and AA) and AA group (37 cases, received only AA on the same acupoints) by a random number table. Each group was treated twice a week for 4 weeks. The Pittsburgh Sleep Quality Index (PSQI) score, Chinese medicine (CM) syndrome score, total effective rate, serum concentrations of MT, Glu, and GABA, and Glu/GABA ratio were compared between the two groups after treatment and at follow-up. The safety of therapy was also evaluated.
RESULTS:
After 4-week treatment, the total scores of PSQI, each PSQI component score, and the CM syndrome scores in both groups all decreased (P<0.05); the serum MT concentrations in both groups all increased (P<0.05). The concentrations of Glu and GABA in the AB+AA group were significantly higher than those in the AA group after treatment (P<0.05). However, there was no significant difference in the ratio of Glu/GABA in both groups before and after treatment (P>0.05). At follow-up, the CM syndrome score in the AB+AA group was significantly lower than that in the AA group (P<0.05). There was no significant difference between the two groups in total effective rates and adverse events (P>0.05).
CONCLUSIONS
Both AB+AA and AA can relieve insomnia symptoms, but a stronger long-term effect were observed for AB+AA. AB+AA can promote the secretion of MT, increase the levels of Glu and GABA more effective than AA, and regulate their imbalance, and thus it may be benificial for treating insomnia.
Humans
;
Acupressure
;
Acupuncture Points
;
Bloodletting
;
Sleep Initiation and Maintenance Disorders/therapy*
;
Sleep Quality
;
Syndrome
;
Students
;
gamma-Aminobutyric Acid
7.Effect of Bmi-1 Expression on Chemotherapy Sensitivity in THP-1 Cells.
Si-Cong DONG ; Ru-Nan JING ; Hao PEI ; Fan LIU ; Bao-Xia ZHAO ; Xiu-Xiang MENG
Journal of Experimental Hematology 2021;29(2):363-368
OBJECTIVE:
To investigate the effect of Bmi-1 expression on the chemosensitivity of THP-1 cells and its relative mechanism.
METHODS:
The pGenesil-2-Bmi-1 1 siRNA, p-MSCV-Bmi-1 plasmid was transfected into THP-1 cells to reduce or increase the expression of Bmi-1. The expression of Bmi-1 mRNA and protein was verified by PCR and Western blot. The effect of camptothecin (CPT) on the proliferation and chemosensitivity of THP-1 cells affected by Bmi-1 gene were detected by MTT assay. The expression of DNA double-strand breaks marker-γ-H2AX was detected by immunofluorescence assay. Mitochondrial membrane potential and apoptosis were observed by flow cytometry. The expression of Cytochrome C, Caspase 3, Bax and BCL-2 was detected by Western blot.
RESULTS:
Silencing Bmi-1 could inhibit proliferation and enhance the sensitivity of THP-1 cells to CPT, while overexpressed Bmi-1 could promote the cell proliferation and attenucate sensitivity of THP-1 cells to CPT. Silencing Bmi-1 could enhance CPT-induced DNA double-strand breaks, decrease mitochondrial membrane potential and promote CPT-induced apoptosis. While increasing Bmi-1 gene expression could attenuate CPT-induced DNA double-strand breaks, enhamce mitochondrial membrane potential and significantly reduce CPT-induced apoptosis of cells.
CONCLUSION
Bmi-1 expression could influence the sensitivity of THP-1 cells to CPT, and its relative mechanism may relate to DNA double-strand breaks and endogenous apoptotic pathways.
Apoptosis
;
Camptothecin/pharmacology*
;
Cell Line, Tumor
;
Cell Proliferation
;
THP-1 Cells
8.Efficacy and safety of Shenyankangfu Tablet, a Chinese patent medicine, for primary glomerulonephritis: A multicenter randomized controlled trial.
Jie WU ; Shu-Wei DUAN ; Hong-Tao YANG ; Yue-Yi DENG ; Wei LI ; Ya-Ni HE ; Zhao-Hui NI ; Yong-Li ZHAN ; Shan LIN ; Zhi-Yong GUO ; Jun ZHU ; Jing-Ai FANG ; Xu-Sheng LIU ; Li-Hua WANG ; Rong WANG ; Nian-Song WANG ; Xiao-Hong CHENG ; Li-Qun HE ; Ping LUO ; Shi-Ren SUN ; Ji-Feng SUN ; Ai-Ping YIN ; Geng-Ru JIANG ; Hong-Yu CHEN ; Wen-Hu LIU ; Hong-Li LIN ; Meng LIANG ; Lu MA ; Ming CHEN ; Li-Qun SONG ; Jian CHEN ; Qing ZHU ; Chang-Ying XING ; Yun LI ; Ji-Ning GAO ; Rong-Shan LI ; Ying LI ; Hao ZHANG ; Ying LU ; Qiao-Ling ZHOU ; Jun-Zhou FU ; Qiang HE ; Guang-Yan CAI ; Xiang-Mei CHEN
Journal of Integrative Medicine 2021;19(2):111-119
BACKGROUND:
Shenyankangfu Tablet (SYKFT) is a Chinese patent medicine that has been used widely to decrease proteinuria and the progression of chronic kidney disease.
OBJECTIVE:
This trial compared the efficacy and safety of SYKFT, for the control of proteinuria in primary glomerulonephritis patients, against the standard drug, losartan potassium.
DESIGN, SETTING, PARTICIPANTS AND INTERVENTION:
This was a multicenter, double-blind, randomized, controlled clinical trial. Primary glomerulonephritis patients, aged 18-70 years, with blood pressure ≤ 140/90 mmHg, estimated glomerular filtration rate (eGFR) ≥ 45 mL/min per 1.73 m
MAIN OUTCOME MEASURES:
The primary outcome was change in the 24-hour proteinuria level, after 48 weeks of treatment.
RESULTS:
A total of 735 participants were enrolled. The percent decline of urine protein quantification in the SYKFT group after 48 weeks was 8.78% ± 2.56% (P = 0.006) more than that in the losartan 50 mg group, which was 0.51% ± 2.54% (P = 1.000) less than that in the losartan 100 mg group. Compared with the losartan potassium 50 mg group, the SYKFT plus losartan potassium 50 mg group had a 13.39% ± 2.49% (P < 0.001) greater reduction in urine protein level. Compared with the losartan potassium 100 mg group, the SYKFT plus losartan potassium 100 mg group had a 9.77% ± 2.52% (P = 0.001) greater reduction in urine protein. With a superiority threshold of 15%, neither was statistically significant. eGFR, serum creatinine and serum albumin from the baseline did not change statistically significant. The average change in TCM syndrome score between the patients who took SYKFT (-3.00 [-6.00, -2.00]) and who did not take SYKFT (-2.00 [-5.00, 0]) was statistically significant (P = 0.003). No obvious adverse reactions were observed in any group.
CONCLUSION:
SYKFT decreased the proteinuria and improved the TCM syndrome scores of primary glomerulonephritis patients, with no change in the rate of decrease in the eGFR. SYKFT plus losartan potassium therapy decreased proteinuria more than losartan potassium therapy alone.
TRIAL REGISTRATION NUMBER
NCT02063100 on ClinicalTrials.gov.
9.Correlation between the Polymorphism of Coagulation-Related Genes and Lower Extremity Deep Venous Thrombosis.
Yao Ru JIANG ; Lei Lei NIU ; Na FENG ; Hao Liang FAN ; Qian Qian JIN ; Qiu Xiang DU ; Jie CAO ; Ying Yuan WANG ; Jun Hong SUN
Journal of Forensic Medicine 2021;37(2):145-150
Objective To investigate the correlation between the polymorphism of 4 coagulation-related genes, rs1799963 (coagulation factor V gene Leiden), rs6025 (prothrombin gene G20210A), rs1042579 (thrombomodulin protein gene c.1418C>T) and rs1801131 (methylenetetrahydroflate reductase gene) and lower extremity deep venous thrombosis (LEDVT). Methods The 4 genotypes mentioned above of 150 LEDVT patients and 153 healthy controls were detected by the kompetitive allele specific polymerase chain reaction (KASP), then related blood biochemical indicators were collected, binary Logistic regression was established to screen the independent risk factors of LEDVT, and the correlation between polymorphism of 4 coagulation-related genes and LEDVT and its indicators under different genetic modes after adjusting confounding factors were analyzed. Results Five variables, D-dimer, fibrinogen degradation product, homocysteine, sex and age might be the risk factors of LEDVT. These variables were put into 4 genetic inheritance models, and adjusted in binary Logistic regression. The results suggested that the mutations of rs1042579 were correlated with LEDVT under dominant inheritance mode. Conclusion The gene polymorphism of rs1799963, rs6025 and rs1801131 has no significant correlation with the formation of LEDVT. The gene polymorphism of rs1042579 plays a role under dominant inheritance mode, and might be an independent risk factor for formation of LEDVT.
Blood Coagulation/genetics*
;
Humans
;
Lower Extremity
;
Polymorphism, Genetic
;
Risk Factors
;
Venous Thrombosis/genetics*
10.Comparative study on HPLC fingerprints between crude and processed Ligustri Lucidi Fructus.
Hao-Jie ZHANG ; Huan-Ru LI ; Zhi-Yi FENG ; Ke LI ; Yan-Ping HU ; Su-Xiang FENG
China Journal of Chinese Materia Medica 2020;45(16):3871-3876
To establish high performance liquid chromatography(HPLC) fingerprints for crude and processed Ligustri Lucidi Fructus,and to evaluate their quality through the similarity calculation and chemical pattern recognition. The separation was performed with Syncronis C_(18) column(4.6 mm × 250 mm, 5 μm), with acetonitrile(A) and 0.1% phosphoric acid solution(B) as the mobile phase for gradient elution, and a detection wavelength of 280 nm. HPLC was used to detect 22 batches of crude and processed Ligustri Lucidi Fructus,and the Similarity Evaluation System for Chromatographic Fingerprint of Traditional Chinese Medicine(2012 Edition) was used to evaluate the similarity among 22 batches. The research on pattern recognition was conducted with cluster analysis(CA), principal component analysis(PCA), and partial least squares discriminate analysis(PLS-DA). HPLC fingerprints of crude and processed Ligustri Lucidi Fructus were established, with similarity ranging from 0.9 to 1.0. The crude and processed Ligustri Lucidi Fructus can be obviously distinguished by using CA, PCA and PLS-DA. According to the results of PLS-DA,11 constituents including hydroxytyrosol, tyrosol, specnuezhenide and oleuropein were the main marker components leading to the difference. The established fingerprint method is stable and reliable, and can provide method basis for quality control of crude and processed Ligustri Lucidi Fructus. Chemical pattern recognition is proved to be helpful in comprehensive quality control and evaluation of Ligustri Lucidi Fructus before and after the process.
Chromatography, High Pressure Liquid
;
Drugs, Chinese Herbal
;
Fruit
;
Ligustrum
;
Medicine, Chinese Traditional

Result Analysis
Print
Save
E-mail